Free Trial

InspireMD (NSPR) News Today

InspireMD logo
$2.36 -0.01 (-0.42%)
Closing price 05/16/2025 04:00 PM Eastern
Extended Trading
$2.34 -0.02 (-0.85%)
As of 05/16/2025 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NSPR Latest News

InspireMD, Inc. stock logo
Parkman Healthcare Partners LLC Has $2.25 Million Stock Holdings in InspireMD, Inc. (NYSE:NSPR)
Parkman Healthcare Partners LLC lifted its holdings in InspireMD, Inc. (NYSE:NSPR - Free Report) by 721.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 854,716 shares of the company's stock after purchasing an additional 750,635 shares during the quarter.
InspireMD, Inc. stock logo
Piper Sandler Lowers InspireMD (NYSE:NSPR) Price Target to $4.00
Piper Sandler reduced their target price on shares of InspireMD from $4.50 to $4.00 and set an "overweight" rating for the company in a research note on Monday.
InspireMD Q1 2025 Earnings Preview
InspireMD, Inc. stock logo
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of InspireMD in a research report on Monday. They issued a "sell" rating on the stock.
InspireMD, Inc. stock logo
Nantahala Capital Management LLC Trims Stock Holdings in InspireMD, Inc. (NYSE:NSPR)
Nantahala Capital Management LLC reduced its stake in InspireMD, Inc. (NYSE:NSPR - Free Report) by 24.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,674,565 shares of the company's stock afte
InspireMD, Inc. stock logo
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of InspireMD in a research report on Sunday. They set a "sell" rating for the company.
InspireMD, Inc. stock logo
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR)
StockNews.com assumed coverage on InspireMD in a report on Saturday. They set a "sell" rating on the stock.
InspireMD, Inc. stock logo
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)
StockNews.com began coverage on shares of InspireMD in a research note on Friday. They set a "sell" rating for the company.
InspireMD files $200M mixed securities shelf
InspireMD, Inc. stock logo
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com
StockNews.com began coverage on InspireMD in a research report on Wednesday. They set a "sell" rating on the stock.
InspireMD reports Q4 EPS (19c) vs (16c) last year
Lake Street Remains a Buy on InspireMD (NSPR)
InspireMD, Inc. stock logo
InspireMD (NYSE:NSPR) Now Covered by StockNews.com
StockNews.com began coverage on shares of InspireMD in a research report on Sunday. They set a "sell" rating on the stock.
InspireMD participates in a conference call with Lake Street
InspireMD, NAMSA partner on CGUARDIANS II trial of CGuard Prime
InspireMD (NSPR) Receives a Buy from Lake Street
InspireMD announces inducement grants under Nasdaq listing rule
InspireMD announces inducement grants
InspireMD Finance Chief Craig Shore To Retire
Get InspireMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

NSPR Media Mentions By Week

NSPR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NSPR
News Sentiment

0.44

0.60

Average
Medical
News Sentiment

NSPR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NSPR Articles
This Week

7

1

NSPR Articles
Average Week

Get InspireMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:NSPR) was last updated on 5/18/2025 by MarketBeat.com Staff
From Our Partners